| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 276.171 | 216.079 | 206.307 | 9.584 | 1.047 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 276.173 | 295.425 | 206.994 | 30.643 | 1.795 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 286.356 | 269.331 | 140.771 | 36.961 | 3.418 | 290 | 0 | 0 | 0 | 0 |
| Gross Profit/Loss - EUR | -10.182 | 26.094 | 66.224 | -6.318 | -1.623 | -290 | 0 | 0 | 0 | 0 |
| Net Profit/Loss - EUR | -10.182 | 21.974 | 62.699 | -7.130 | -1.676 | -290 | 0 | 0 | 0 | 0 |
| Employees | 8 | 8 | 4 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Farmacom Carpati Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 46.045 | 38.654 | 30.932 | 4.152 | 1.920 | 1.610 | 1.574 | 1.579 | 1.574 | 1.566 |
| Current Assets | 105.603 | 43.043 | 25.571 | 22.973 | 4.266 | 4.169 | 4.076 | 4.089 | 4.076 | 4.054 |
| Inventories | 47.092 | 11.900 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 49.291 | 11.842 | 846 | 864 | 841 | 825 | 807 | 809 | 807 | 802 |
| Cash | 9.220 | 19.301 | 24.725 | 22.109 | 3.425 | 3.344 | 3.270 | 3.280 | 3.270 | 3.252 |
| Shareholders Funds | -31.847 | -11.218 | 51.670 | 25.904 | 5.980 | 5.577 | 5.453 | 5.470 | 5.453 | 5.423 |
| Social Capital | 2.223 | 2.200 | 2.163 | 2.123 | 2.082 | 2.043 | 1.997 | 2.003 | 1.997 | 1.986 |
| Debts | 183.495 | 92.916 | 4.833 | 1.221 | 206 | 202 | 198 | 198 | 198 | 196 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6820 - 6820" | |||||||||
| CAEN Financial Year |
6820
|
|||||||||
Comments - Farmacom Carpati Srl